The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of a novel whole blood RT-PCR assay measuring AR-V7 expression with outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate (ABI).
 
Tilman Todenhöfer
No Relationships to Disclose
 
Arun Azad
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Astellas Pharma
 
Craig Stewart
No Relationships to Disclose
 
Jian Gao
No Relationships to Disclose
 
Bernhard J. Eigl
No Relationships to Disclose
 
Peter C. Black
Honoraria - Cubist; Pendopharm
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; BioCancell; Cubist; Janssen Oncology; Novartis; Sitka
Speakers' Bureau - Abbvie; Ferring; Janssen Oncology; Novartis; Red Leaf Medical
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
 
Anthony M. Joshua
Research Funding - Janssen-Cilag
 
Kim N. Chi
Honoraria - Astellas Pharma; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi; Takeda
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Exelixis (Inst); Janssen (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst); Tokai Pharmaceuticals (Inst)